IDEX Corporation (IEX)

In the past six months, IDEX Corp. experienced several stock events. IDEX reported Q4 2025 earnings exceeding analyst estimates, leading to an initial surge in shares, but the stock later dipped due to conservative 2026 guidance. The Q4 2025 report highlighted strong order growth, driven by the Health & Science Technologies segment. The company utilized $73 million for share repurchases in Q4 2025 and $248 million for the full year 2025. Argus Research upgraded IDEX Corp. to "Buy" with a $240 price target in February 2026, and RBC Capital raised its price target to $244 from $211, maintaining an "Outperform" rating. In the last year, IDEX shares hit a 52-week high of $217.16 and a 52-week low of $153.36.

IDEX Corporation experiences a level load of sales between the third and fourth quarters, reflective of its typical historical seasonal cadence. Demand is influenced by diverse industrial end markets, regulatory standards, infrastructure maintenance cycles, and technological modernization. The Health & Science Technologies segment has shown strong order momentum, while the Fire & Safety/Diversified Products segment has faced headwinds. The diversified nature of its operations provides resilience against sector-specific downturns.

IDEX Corporation is a global engineered products company operating in the industrial sector, focusing on industrial machinery, supplies, and components. The company is divided into three segments: Fluid & Metering Technologies (FMT), which produces fluid-handling systems; Health & Science Technologies (HST), which focuses on precision engineered fluidics; and Fire & Safety/Diversified Products (FSDP), which manufactures firefighting equipment and engineered devices. IDEX's products are used in life sciences, water, energy, and industrial manufacturing.

IDEX Corporation has a significant global presence with manufacturing operations in over 20 countries across five continents. The company has expanded into emerging markets, recognizing their growth potential across all segments.

IDEX Corporation emphasizes its role as a provider of "Trusted Solutions, Improving Lives™" through engineered components and solutions, with a history of innovation, diversity, and excellence. Recent strategic acquisitions have expanded its expertise and offerings, contributing positively to its market position. The strong performance in its Health & Science Technologies segment enhances its reputation. Conservative 2026 guidance led to mixed investor sentiment, which could be seen as a minor reputational challenge in the short term.

IDEX Corporation's ownership is predominantly institutional, with key shareholders including Vanguard Group Inc., Wellington Management Group Llp, and BlackRock, Inc. Institutional investors hold approximately 97.96% of the outstanding shares. Individual insiders hold a small percentage of the company's stock, approximately 0.185%, and there have been insider purchases in the past six months.